Kolhapur, India

Abhijeet Arun Lambe

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Biocon Limited. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abhijeet Arun Lambe. Retrieved from https://idiyas.com/inventor/abhijeet-arun-lambe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Abhijeet Arun Lambe: Innovator in GLP-1 Analogues Purification

Introduction

Abhijeet Arun Lambe is a notable inventor based in Kolhapur, India. He has made significant contributions to the field of pharmaceuticals, particularly in the purification of GLP-1 analogues. His work is essential for enhancing the efficacy and safety of diabetes treatments.

Latest Patents

Abhijeet holds a patent for the "Purification of GLP-1 analogues." This invention focuses on the purification of liraglutide using selective ion-pairing agents in reversed phase-high performance liquid chromatography. This method is crucial for purifying crude liraglutide from closely related impurities, ensuring a higher quality product for medical use. He has 1 patent to his name.

Career Highlights

Abhijeet is currently employed at Biocon Limited, a leading biopharmaceutical company. His role involves research and development, where he applies his expertise to innovate and improve pharmaceutical processes. His work contributes to the advancement of treatments for various health conditions.

Collaborations

Abhijeet has collaborated with notable colleagues, including Ramachandran Ganesh and Onkar Prakash Santan. These partnerships enhance the research environment and foster innovation within the company.

Conclusion

Abhijeet Arun Lambe is a distinguished inventor whose work in the purification of GLP-1 analogues is paving the way for improved diabetes treatments. His contributions to Biocon Limited and the pharmaceutical industry are commendable and impactful.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…